When someone hears their liver numbers are a little high, or gets told at a routine checkup that "there's something on the liver," the questions tend to be the same. Isn't an ultrasound enough? Why are they asking me to do a CT on top of that? Do I really need to go all the way to an MRI? The truth is, these three aren't competing tests, they're tools that each happen to be good at something different. The real key is deciding which one to use first and how far to take it.
The first test you usually run into is liver ultrasound. There's no radiation, the exam is quick, and it's easier on the wallet. For people at high risk of liver cancer, such as those with chronic hepatitis B or C or cirrhosis, the regular follow-up done every six months is also mostly built around ultrasound. That said, it has clear limits. Because the operator moves the probe by hand, results depend on the examiner's skill, and if there's a lot of gas in the abdomen or the person has a larger build, parts of the liver can be hard to see. So when ultrasound picks up a suspicious shadow, the workup doesn't stop there; it moves on to the next step.
Next comes CT. Contrast dye is injected into a vein and the liver is scanned several times at timed intervals. Liver cancer has a telltale pattern of pulling in a lot of blood from the arteries and then washing out quickly, so reading that contrast flow makes it considerably easier to tell a tumor apart from a benign lump. A big advantage is that a single scan can sweep broadly across the whole liver and also check the surrounding organs, lymph nodes, and whether blood vessels are involved. The trade-off is radiation exposure, and because contrast dye is used, anyone with significantly reduced kidney function or a past contrast allergy must be sure to tell the medical team in advance.
MRI is the test that examines soft tissue in the finest detail of the three. There's no radiation, and with a liver-specific contrast agent it's strong at distinguishing small lesions around a centimeter, or characterizing nodules that looked ambiguous on CT. In the gray zone where the call between benign and malignant goes either way, it often delivers the deciding answer. The downsides are that the exam takes a while, and there are several stretches where you have to hold your breath, so for people who find breath-holding difficult the images can come out blurred. If being inside a narrow tube is hard for you because of claustrophobia, it's worth discussing that ahead of time too.
To sum up, the flow goes like this. Routine surveillance for high-risk patients is done with ultrasound; if something turns up, CT or MRI is used to characterize it; and when a treatment plan is being made or a small lesion needs to be confirmed once and for all, MRI lends its weight. The tests that make you think "why are we scanning again?" are actually structured so that the later one fills in what the earlier one might have missed. There's a reason the order is set the way it is.
What's written here only lays out the big picture to help you understand these tests. Which exam is right for your particular liver is, in the end, most accurately decided by talking it over directly with your doctor in the consultation room.